Atractylenolide-I Sensitizes Human Ovarian Cancer Cells to Paclitaxel by Blocking Activation of TLR4/MyD88-dependent Pathway

Paclitaxel, a known TLR4 ligand, leads to activation of TLR4/MyD88-dependent pathway that mediates chemoresistance and tumor progression in epithelial ovarian carcinoma (EOC). Atractylenolide-I (AO-I), a novel TLR4-antagonizing agent, inhibits TLR4 signaling by interfering with the binding of LPS or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huang, Jian-Ming, Zhang, Guo-Nan, Shi, Yu, Zha, Xiao, Zhu, Yi, Wang, Miao-Miao, Lin, Qing, Wang, Wen, Lu, Hai-Yan, Ma, Shi-Qi, Cheng, Jia, Deng, Bi-Fang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899591/
https://ncbi.nlm.nih.gov/pubmed/24452475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep03840
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados